Oak Hill Wealth Advisors’s AbbVie ABBV Stock Holding History

Oak Hill Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.03M	Sell	17,395 -108	-0.6%	-$22K	0.75%	25
2025 Q2	$3.32M	Sell	17,503 -176	-1%	-$32.7K	0.69%	26
2025 Q1	$3.7M	Sell	17,679 -21	-0.1%	-$4.08K	0.86%	26
2024 Q4	$3.15M	Buy	+17,700	New	+$3.25M	0.75%	26
2024 Q3	–	Sell	-17,109	Closed	-$3.19M	–	117
2024 Q2	$2.93M	Buy	+17,109	New	+$2.83M	0.89%	18
2024 Q1	–	Sell	-17,835	Closed	-$3.07M	–	109
2023 Q4	$2.76M	Sell	17,835 -443	-2%	-$64.6K	0.95%	16
2023 Q3	$2.72M	Buy	18,278 +112	+0.6%	+$16.4K	1.05%	16
2023 Q2	$2.45M	Sell	18,166 -799	-4%	-$117K	0.9%	17
2023 Q1	$3.02M	Sell	18,965 -102	-0.5%	-$15.6K	1.19%	16
2022 Q4	$3.08M	Buy	+19,067	New	+$2.92M	1.27%	16

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Hill Wealth Advisors's ABBV Position: Q3 2025 in Review

Oak Hill Wealth Advisors reduced its AbbVie (ABBV) stake by 0.62% in Q3 2025, selling an estimated $22K and leaving 17,395 shares worth $4.03M. The position accounts for 0.75% of the portfolio, ranked #25.

Oak Hill Wealth Advisors first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Oak Hill Wealth Advisors held 17,395 shares of AbbVie worth $4.03M as of Q3 2025.
Oak Hill Wealth Advisors sold 108 AbbVie shares in Q3 2025, an estimated $22K.
AbbVie made up 0.75% of Oak Hill Wealth Advisors's portfolio in Q3 2025, its #25 holding.
Oak Hill Wealth Advisors first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Oak Hill Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.